Abivax says Bank of America beneficial stake rises to 6.49% of capital, 6.31% of voting rights

Bank Of America
Abivax

Bank Of America

BAC

0.00

Abivax

ABVX

0.00
  • Bank of America lifted its stake in Abivax above the 5% threshold on May 28.
  • Holding totaled 5,149,637 shares, equal to 6.49% of share capital.
  • Voting rights stake reached 6.31%, or 5,149,637 votes.
  • Move driven by market purchases, with additional exposure via assimilated holdings including swaps and a physically settled call option at EUR 130.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abivax SA published the original content used to generate this news brief on June 01, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.